cdk1 cdk2 Search Results


93
MedChemExpress anti cdk2
Anti Cdk2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk1+cdk2/CDK2+Antibody/pm41039223-77-0-3
Average 93 stars, based on 1 article reviews
anti cdk2 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

N/A
Phospho-CDK2/CDK1 (Thr160/Thr161) antibody detects cyclin dependent kinase 2 and cyclin dependent kinase 1 when phosphorylated at their critical threonine residues required for activation. CDK2, encoded by the CDK2 gene, and CDK1, encoded by the CDK1
  Buy from Supplier

93
Santa Cruz Biotechnology cdk1 sc 53219 antibodies
Fig. 8. Proposed signal pathways. NT157 caused ROS generation and DNA damage, which activated p21 and p27, and subsequently lunched S-phase and M-phase cell cycle arrest through regulating cyclin A1, CDK2, cyclin B1 and <t>CDK1.</t> NT157 also dysfunctioned MAPKs, PI3K/AKT and EGFR-STAT3 pathways, and enhanced TRAIL-induced glioma cells apoptosis by up-regulating DR5 expression.
Cdk1 Sc 53219 Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk1+cdk2/Cdk1%2FCdk2+Antibody/pm36076591-52-3-9
Average 93 stars, based on 1 article reviews
cdk1 sc 53219 antibodies - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

96
Carna Inc gst
Fig. 8. Proposed signal pathways. NT157 caused ROS generation and DNA damage, which activated p21 and p27, and subsequently lunched S-phase and M-phase cell cycle arrest through regulating cyclin A1, CDK2, cyclin B1 and <t>CDK1.</t> NT157 also dysfunctioned MAPKs, PI3K/AKT and EGFR-STAT3 pathways, and enhanced TRAIL-induced glioma cells apoptosis by up-regulating DR5 expression.
Gst, supplied by Carna Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk1+cdk2/ACTR2B/us11248004-1035-33-34
Average 96 stars, based on 1 article reviews
gst - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

94
Carna Inc flt3 construct
Fig. 8. Proposed signal pathways. NT157 caused ROS generation and DNA damage, which activated p21 and p27, and subsequently lunched S-phase and M-phase cell cycle arrest through regulating cyclin A1, CDK2, cyclin B1 and <t>CDK1.</t> NT157 also dysfunctioned MAPKs, PI3K/AKT and EGFR-STAT3 pathways, and enhanced TRAIL-induced glioma cells apoptosis by up-regulating DR5 expression.
Flt3 Construct, supplied by Carna Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk1+cdk2/BTN-ABL/pm34038857-112-35-9
Average 94 stars, based on 1 article reviews
flt3 construct - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

N/A
CDK1 CDK2 CDK3 pT14 Antibody is a Rabbit Polyclonal against CDK1 CDK2 CDK3 pT14
  Buy from Supplier

N/A
Boster Bio Anti-Phospho-Cdk1/2/3 (T14) CDK2 Antibody catalog # A00166T14. Tested in ELISA, IF, WB applications. This antibody reacts with Human, Monkey, Mouse, Rat.
  Buy from Supplier

N/A
Rabbit anti-Human Phospho-CDK1/CDK2/CDK3 Polyclonal Antibody
  Buy from Supplier

N/A
Phospho-CDK1/CDK2 (Thr14) Polyclonal Antibody for Western Blot
  Buy from Supplier

N/A
CDK1/CDK2 Monoclonal Antibody for Western Blot, ELISA
  Buy from Supplier

N/A
Rabbit anti-Human CDK1/CDK2/CDK3 Polyclonal Antibody
  Buy from Supplier

N/A
anti-Human Phospho-CDK1/CDK2/CDK3 Monoclonal Antibody
  Buy from Supplier

Image Search Results


Fig. 8. Proposed signal pathways. NT157 caused ROS generation and DNA damage, which activated p21 and p27, and subsequently lunched S-phase and M-phase cell cycle arrest through regulating cyclin A1, CDK2, cyclin B1 and CDK1. NT157 also dysfunctioned MAPKs, PI3K/AKT and EGFR-STAT3 pathways, and enhanced TRAIL-induced glioma cells apoptosis by up-regulating DR5 expression.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Article Title: NT157 inhibits cell proliferation and sensitizes glioma cells to TRAIL-induced apoptosis by up-regulating DR5 expression.

doi: 10.1016/j.biopha.2022.113502

Figure Lengend Snippet: Fig. 8. Proposed signal pathways. NT157 caused ROS generation and DNA damage, which activated p21 and p27, and subsequently lunched S-phase and M-phase cell cycle arrest through regulating cyclin A1, CDK2, cyclin B1 and CDK1. NT157 also dysfunctioned MAPKs, PI3K/AKT and EGFR-STAT3 pathways, and enhanced TRAIL-induced glioma cells apoptosis by up-regulating DR5 expression.

Article Snippet: CyclinA (sc-271682), anti-p21(sc-6246), CDK1 (sc-53219) antibodies were purchased from Santa Cruz Biotechnology (Shanghai, China). β-actin antibody and IgG were bought from Beijing zhongshan Jinqiao Biotechnology (Beijing, China). p27 (#3686), CDK2 (#18048), Cyclin B1 (#12231), PARP (#9542), Caspase-3 (#9662), PCNA (#13110), Ku70 (#4588), Ku80 (#2753), γ-H2AX (#80312), p-ERK (#4370), ERK (#4695), p-p38 (#4511), p38 (#8690), p-JNK (#9255), JNK (#9252), Akt (#4685), p-Akt (#4060), EGFR (#8083), p-Stat3 (#9145), Stat3 (#9139), DR5(#69400), DR4(#42533) were all purchased from Cell Signaling Technology (CST, USA).

Techniques: Expressing